Tryptamine initiates new ‘magic mushroom’ clinical trial
In a world first, Tryptamine Therapeutics is using intravenously delivered psilocybin in a binge-eating disorder clinical trial.
News
Buffett steps back as ASX runs a bit hot
As Buffett steps back after a legendary run, does his favourite market gauge suggest the Aussie market might be running a little rich?
ASX stock joins space drug test
Space might just be the perfect lab, as Aussie outfit Trajan helps to track how the pills hit when you’re floating.
Everything you need to know before the ASX opens.
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
Gold shines bright despite minor market dip
Despite a minor dip to the overall ASX, rising gold prices lifted gold stocks, pushing the ASX Gold index up 4.3%.
WCN grows copper prospectivity at Rae
Assays from RC drilling have flagged a globally significant copper intersection for White Cliff Minerals at its Rae copper project in Canada.
ASX swings, gold glows, all eyes on Fed
Markets have wobbled on Tuesday as Wall Street paused gains. ASX stocks are split between bright spots such as Vicinity and caution from WiseTech.
Big name biotechs generate bonanza gains
Investors who picked the bottom of the recent large cap biotech rout have snared enviable windfall gains.
ASX opens flat as new tariff talks weigh
The ASX has had a quiet start, down just 0.05pc in the first hour. With six sectors up and five sectors down, the market could go either way.
Which metals won in April?
Gold and uranium rose in April but the impact of the US-China trade war loomed large over commodity markets.
Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
A new mineral sands hotspot in Sri Lanka
With major regulatory hurdles cleared, production is within reach at Titanium Sands’ Mannar Island project.
Uranium rebound? Five reasons it could happen
Uranium prices are showing renewed signs of life. Which juniors have the most leverage if the comeback goes nuclear?
Trump powers copper dream
Copper explorers in the United States are toasting the best regulatory conditions they’ve seen in years in the early days of Trump 2.0.
WTF: Arovella Therapeutics
Arovella Therapeutic’s CEO reveals what iNKT cell therapies are, how they work and why they are promising for cancer treatment.
Tony’s Takeaway: Surfs up on the quarterly wrap wave
Tony Locantro returns to the desk after a pit stop in Sanur, Indonesia, where he has learned the art of riding the quarterly wave.
Resources Top 50: These ASX stocks were saw the biggest gains in April
The big resources winners in April were looking for gold, copper and rare earths, with DY6 taking top spot for biggest monthly stock gain.
EIS drives greenfields exploration in WA
Here are some of the companies whose greenfield exploration that will benefit from the 31st round of WA’s exploration incentive scheme.
ASX breaks seven-day winning streak to fall almost 1pc
The ASX broke a more than week-long winning streak to fall across the board today, losing almost a full percentage point with particular weakness in the Energy and Financials sectors.
Gold Road relents to offer from Gold Fields
One of the “worst kept secrets” in the gold M&A scene is out in the open with Gold Road relenting to a “best and final” offer from Gold Fields in a $3.7 billion buyout.
Energy stocks crumble but XPON lights up the ASX
Westpac dragged the banks lower, oil giants slipped, but Qantas soared on cheaper fuel and XPON was up 300pc on acquisition news.
ASX April winners and losers
The S&P/ASX 200 healthcare index rose 2.16% in April, as the local market showed resilience to geopolitical and economics headwinds.
Norwest’s Bulgera good as gold
With a mining lease in place and over 200,000oz of gold in the ground, could Norwest’s Bulgera be the deepest value junior gold project in WA?
Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
Gold prospects shine for Javelin
At current gold prices explorers could dig deposits worth more than their market caps. Garimpeiro thinks Javelin Minerals could fit that bill.
Original URL: https://www.theaustralian.com.au/business/stockhead/news